首页 > 最新文献

The Lancet Regional Health: Western Pacific最新文献

英文 中文
Cancer survivorship in the Western Pacific: from differences to shared-goals and from challenges to opportunities 西太平洋地区的癌症幸存者:从差异到共同目标,从挑战到机遇
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-18 DOI: 10.1016/j.lanwpc.2025.101749
Raymond Javan Chan , Reegan Knowles , Carolyn Taylor , Nirmala Bhoo Pathy , Ke Yu , Karolina Lisy , Julia Lai-Kwon , Miyako Tsuchiya , Yan Lou , Wendy Lam , Michael Jefford
The Western Pacific region consists of 38 countries and approximately one quarter of the world population. Over 17 million people in the region have a personal history of cancer, necessitating effective survivorship care approaches for optimal outcomes and experiences. There are substantial differences in population and income and resource availability between countries within the region which impacts cancer survivorship care. Likewise, varying healthcare systems and models of survivorship care (e.g., primary care-led, patient-led etc.) affect the survivorship experience and outcome of people affected by cancer. Despite differences across Western Pacific countries, issues facing cancer survivors are similar, with shared challenges including lack of focus on survivorship care, adoption of a holistic approach, and workforce availability. Various approaches to cancer survivorship are being developed and implemented across the region, but a region-wide, coordinated approach is needed, involving thoughtful leadership and sharing of ideas to achieve better outcomes.
西太平洋区域由38个国家组成,约占世界人口的四分之一。该地区有超过1700万人有个人癌症病史,因此需要有效的生存护理方法来获得最佳结果和体验。本区域各国之间在人口、收入和资源可得性方面存在巨大差异,这影响到癌症幸存者护理。同样,不同的医疗保健系统和生存护理模式(例如,初级保健主导,患者主导等)会影响癌症患者的生存体验和结果。尽管西太平洋国家之间存在差异,但癌症幸存者面临的问题是相似的,面临着共同的挑战,包括缺乏对幸存者护理的关注,采用整体方法,以及劳动力的可用性。该地区正在制定和实施各种癌症幸存者方法,但需要一种全区域协调的方法,包括深思熟虑的领导和分享想法,以取得更好的结果。
{"title":"Cancer survivorship in the Western Pacific: from differences to shared-goals and from challenges to opportunities","authors":"Raymond Javan Chan ,&nbsp;Reegan Knowles ,&nbsp;Carolyn Taylor ,&nbsp;Nirmala Bhoo Pathy ,&nbsp;Ke Yu ,&nbsp;Karolina Lisy ,&nbsp;Julia Lai-Kwon ,&nbsp;Miyako Tsuchiya ,&nbsp;Yan Lou ,&nbsp;Wendy Lam ,&nbsp;Michael Jefford","doi":"10.1016/j.lanwpc.2025.101749","DOIUrl":"10.1016/j.lanwpc.2025.101749","url":null,"abstract":"<div><div>The Western Pacific region consists of 38 countries and approximately one quarter of the world population. Over 17 million people in the region have a personal history of cancer, necessitating effective survivorship care approaches for optimal outcomes and experiences. There are substantial differences in population and income and resource availability between countries within the region which impacts cancer survivorship care. Likewise, varying healthcare systems and models of survivorship care (e.g., primary care-led, patient-led etc.) affect the survivorship experience and outcome of people affected by cancer. Despite differences across Western Pacific countries, issues facing cancer survivors are similar, with shared challenges including lack of focus on survivorship care, adoption of a holistic approach, and workforce availability. Various approaches to cancer survivorship are being developed and implemented across the region, but a region-wide, coordinated approach is needed, involving thoughtful leadership and sharing of ideas to achieve better outcomes.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"65 ","pages":"Article 101749"},"PeriodicalIF":8.1,"publicationDate":"2025-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145577834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Area-level socioeconomic status inequalities shape patterns of antimicrobial resistance in China, 2014–2023: a Bayesian spatiotemporal modelling analysis 2014-2023年中国地区社会经济地位不平等对抗菌素耐药性的影响:贝叶斯时空模型分析
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-13 DOI: 10.1016/j.lanwpc.2025.101745
Yi Yang , Jiani Jiang , Can Chen , Rongrong Qu , Yi Liu , Chen Xu , Xiangkun Zeng , Xiaofan Li , Yi Li , Weili Lin , Lili Huang , Mi Zhou , Mengsha Chen , Rong Zhang , Shigui Yang , Ning Dong

Background

Antimicrobial resistance (AMR) represents an escalating global health challenge, with socioeconomic status (SES) being a significant influencing factor. This study aimed to quantify area-level SES and assess its association with drug-resistant bacteria in China.

Methods

AMR data were collected from China Antimicrobial Resistance Surveillance System (CARSS, 2014–2023). Area-level SES across China was captured by County-level Area Deprivation Index (CADI) and Townsend Deprivation Index (TDI). Spatiotemporal distributions of drug-resistant bacteria were explored by spatial autocorrelation and spatiotemporal scan analyses. Key AMR risk factors were identified by GeoDetector analysis. Six Bayesian models were established through the Bayesian spatiotemporal modelling analysis. The Bayesian Spatiotemporal Interaction Hierarchy Model (BSTIHM), demonstrating superior estimative accuracy, was selected to forecast nationwide AMR patterns.

Findings

AMR profiles were obtained for totally 34,442,268 isolates of thirteen types of drug-resistant bacteria. The distributions of these bacteria exhibited manifest spatiotemporal heterogeneity nationwide. Both CADI and TDI consistently revealed a distinct socioeconomic gradient, with low area-level SES in western regions, medium in central regions, and high in eastern regions. Spatiotemporal clusters of drug-resistant bacteria were mainly observed in low SES regions. Lower area-level SES (odds ratio (OR) range: 1.054–1.254) and higher antimicrobial usage intensity (OR range: 1.022–1.174) contributed to higher risk of all thirteen types of drug-resistant bacteria. Meanwhile, total wastewater discharge (OR range: 1.064–1.280), PM2.5 (OR range: 1.031–1.135), and number of healthcare technicians per 10,000 people (OR range: 1.035–1.310) were correlated with risks of most drug-resistant bacteria. Estimated risks for all thirteen types of drug-resistant bacteria were increased in low and middle area-level SES regions based on the BSTIHM.

Interpretation

Area-level SES is a pivotal driver of AMR risk, which might be caused by antibiotic overuse and environmental pollution. Targeted investments in healthcare and environmental systems in lower area-level SES regions are essential to effectively reduce AMR burden.

Funding

National Key R&D Program of China, National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, and Natural Science Foundation of Jiangsu Province.
抗生素耐药(AMR)是一个不断升级的全球健康挑战,社会经济地位(SES)是一个重要的影响因素。本研究旨在量化中国地区SES水平并评估其与耐药菌的关系。方法收集2014-2023年中国抗微生物药物耐药性监测系统(CARSS)的samr数据。采用县级区域剥夺指数(CADI)和汤森德剥夺指数(TDI)对全国区域级社会经济状况进行测度。通过空间自相关分析和时空扫描分析探讨耐药菌的时空分布。通过GeoDetector分析确定关键的AMR危险因素。通过贝叶斯时空建模分析,建立了6个贝叶斯模型。结果表明,贝叶斯时空相互作用层次模型(BSTIHM)具有较好的预测精度,可用于预测全国AMR格局。13种耐药菌共34,442,268株获得了samr谱。这些细菌在全国范围内的分布具有明显的时空异质性。CADI和TDI均表现出明显的社会经济梯度,西部低,中部中等,东部高。耐药菌的时空分布主要集中在低SES区域。较低的地区SES (OR范围:1.054 ~ 1.254)和较高的抗菌药物使用强度(OR范围:1.022 ~ 1.174)是13种耐药菌发生风险较高的因素。同时,污水排放总量(OR范围:1.064 ~ 1.280)、PM2.5 (OR范围:1.031 ~ 1.135)和每万人卫生技术人员(OR范围:1.035 ~ 1.310)与大多数耐药菌的风险相关。基于BSTIHM的13种耐药细菌的估计风险在中低区域SES区域均有所增加。区域SES是AMR风险的关键驱动因素,可能由抗生素过度使用和环境污染引起。有针对性地投资于社会经济地位较低地区的卫生保健和环境系统,对于有效减轻抗菌素耐药性负担至关重要。国家重点研发计划,国家自然科学基金,浙江省自然科学基金,江苏省自然科学基金。
{"title":"Area-level socioeconomic status inequalities shape patterns of antimicrobial resistance in China, 2014–2023: a Bayesian spatiotemporal modelling analysis","authors":"Yi Yang ,&nbsp;Jiani Jiang ,&nbsp;Can Chen ,&nbsp;Rongrong Qu ,&nbsp;Yi Liu ,&nbsp;Chen Xu ,&nbsp;Xiangkun Zeng ,&nbsp;Xiaofan Li ,&nbsp;Yi Li ,&nbsp;Weili Lin ,&nbsp;Lili Huang ,&nbsp;Mi Zhou ,&nbsp;Mengsha Chen ,&nbsp;Rong Zhang ,&nbsp;Shigui Yang ,&nbsp;Ning Dong","doi":"10.1016/j.lanwpc.2025.101745","DOIUrl":"10.1016/j.lanwpc.2025.101745","url":null,"abstract":"<div><h3>Background</h3><div>Antimicrobial resistance (AMR) represents an escalating global health challenge, with socioeconomic status (SES) being a significant influencing factor. This study aimed to quantify area-level SES and assess its association with drug-resistant bacteria in China.</div></div><div><h3>Methods</h3><div>AMR data were collected from China Antimicrobial Resistance Surveillance System (CARSS, 2014–2023). Area-level SES across China was captured by County-level Area Deprivation Index (CADI) and Townsend Deprivation Index (TDI). Spatiotemporal distributions of drug-resistant bacteria were explored by spatial autocorrelation and spatiotemporal scan analyses. Key AMR risk factors were identified by GeoDetector analysis. Six Bayesian models were established through the Bayesian spatiotemporal modelling analysis. The Bayesian Spatiotemporal Interaction Hierarchy Model (BSTIHM), demonstrating superior estimative accuracy, was selected to forecast nationwide AMR patterns.</div></div><div><h3>Findings</h3><div>AMR profiles were obtained for totally 34,442,268 isolates of thirteen types of drug-resistant bacteria. The distributions of these bacteria exhibited manifest spatiotemporal heterogeneity nationwide. Both CADI and TDI consistently revealed a distinct socioeconomic gradient, with low area-level SES in western regions, medium in central regions, and high in eastern regions. Spatiotemporal clusters of drug-resistant bacteria were mainly observed in low SES regions. Lower area-level SES (odds ratio (OR) range: 1.054–1.254) and higher antimicrobial usage intensity (OR range: 1.022–1.174) contributed to higher risk of all thirteen types of drug-resistant bacteria. Meanwhile, total wastewater discharge (OR range: 1.064–1.280), PM<sub>2.5</sub> (OR range: 1.031–1.135), and number of healthcare technicians per 10,000 people (OR range: 1.035–1.310) were correlated with risks of most drug-resistant bacteria. Estimated risks for all thirteen types of drug-resistant bacteria were increased in low and middle area-level SES regions based on the BSTIHM.</div></div><div><h3>Interpretation</h3><div>Area-level SES is a pivotal driver of AMR risk, which might be caused by antibiotic overuse and environmental pollution. Targeted investments in healthcare and environmental systems in lower area-level SES regions are essential to effectively reduce AMR burden.</div></div><div><h3>Funding</h3><div>National Key R&amp;D Program of China, National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, and Natural Science Foundation of Jiangsu Province.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"65 ","pages":"Article 101745"},"PeriodicalIF":8.1,"publicationDate":"2025-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145519338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global need, regional action: opportunities to improve cancer survivorship care in the Western Pacific 全球需求,区域行动:改善西太平洋癌症幸存者护理的机会
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-12 DOI: 10.1016/j.lanwpc.2025.101748
Michael Jefford , Fiona Crawford-Williams , Carolyn Taylor , Miyako Takahashi , Wendy W.T. Lam , Alexandre Chan , Bogda Koczwara , Yan Lou , Raymond J. Chan
The Western Pacific region faces a significant cancer burden with over 12.8 million cancer survivors. Cancer survivorship care remains inconsistent across the region but is important regardless of diversity in healthcare systems and resources within countries. Cultural factors deeply influence survivorship experiences; thus, recognition of the importance of traditional medicine and the role of community-based support in survivorship care is needed. In this viewpoint, we highlight opportunities for regional collaboration to improve cancer survivorship outcomes, and advocate for incorporation of survivorship priorities into national cancer control plans. We call for coordinated action involving international organizations, local governments, and cancer survivor voices to deliver responsive, equitable survivorship care. Education, policy reform, and multinational partnerships are essential to address disparities and improve outcomes across the region.
西太平洋区域面临着严重的癌症负担,有超过1280万癌症幸存者。癌症幸存者护理在整个地区仍然不一致,但无论各国医疗保健系统和资源的多样性如何,它都很重要。文化因素深刻影响生存体验;因此,需要认识到传统医学的重要性以及社区支持在生存护理中的作用。在这一观点中,我们强调了区域合作的机会,以改善癌症幸存者的结果,并倡导将幸存者的优先事项纳入国家癌症控制计划。我们呼吁国际组织、地方政府和癌症幸存者采取协调一致的行动,提供及时、公平的幸存者护理。教育、政策改革和跨国伙伴关系对于解决整个地区的差距和改善成果至关重要。
{"title":"Global need, regional action: opportunities to improve cancer survivorship care in the Western Pacific","authors":"Michael Jefford ,&nbsp;Fiona Crawford-Williams ,&nbsp;Carolyn Taylor ,&nbsp;Miyako Takahashi ,&nbsp;Wendy W.T. Lam ,&nbsp;Alexandre Chan ,&nbsp;Bogda Koczwara ,&nbsp;Yan Lou ,&nbsp;Raymond J. Chan","doi":"10.1016/j.lanwpc.2025.101748","DOIUrl":"10.1016/j.lanwpc.2025.101748","url":null,"abstract":"<div><div>The Western Pacific region faces a significant cancer burden with over 12.8 million cancer survivors. Cancer survivorship care remains inconsistent across the region but is important regardless of diversity in healthcare systems and resources within countries. Cultural factors deeply influence survivorship experiences; thus, recognition of the importance of traditional medicine and the role of community-based support in survivorship care is needed. In this viewpoint, we highlight opportunities for regional collaboration to improve cancer survivorship outcomes, and advocate for incorporation of survivorship priorities into national cancer control plans. We call for coordinated action involving international organizations, local governments, and cancer survivor voices to deliver responsive, equitable survivorship care. Education, policy reform, and multinational partnerships are essential to address disparities and improve outcomes across the region.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"65 ","pages":"Article 101748"},"PeriodicalIF":8.1,"publicationDate":"2025-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145486314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk of dengue following prior SARS-CoV-2 infection: a population-based cohort study 先前SARS-CoV-2感染后发生登革热的风险:一项基于人群的队列研究
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-01 DOI: 10.1016/j.lanwpc.2025.101727
Liang En Wee , Jue Tao Lim , An Ting Tay , Borame Dickens , Pei Ma , Calvin Chiew , Po Ying Chia , Yee Sin Leo , Lee Ching Ng , David Chien Lye , Kelvin Bryan Tan

Background

DENV-infection and SARS-CoV-2 are now endemic in tropical regions; interactions may exist, given antigenic cross-reactivity and cross-protection. Risk of subsequent DENV-infection following prior COVID-19 was evaluated in a population-based adult cohort.

Methods

Retrospective cohort study including all Singaporeans ≥18 years. National registries were used to construct contemporaneous SARS-CoV-2-infected/test-negative cohorts from 1st Sept 2021–31st Dec 2022 during Delta/Omicron emergence. COVID-19 vaccination status was classified using the national-immunization-registry. Risk of DENV-infection recorded in the national registry 31–300 days post-COVID-19 was contrasted against test-negatives using overlap-weighted Cox regression. Risk of other infections (invasive-pneumococcal-disease/tuberculosis/melioidosis/leptospirosis) were assessed as negative-outcome controls, and risk of DENV-infection post-influenza vaccination was assessed as a negative-exposure control.

Findings

1,324,250 COVID-19 cases (predominantly vaccine-breakthrough mild Omicron infections) and 1,434,851 test-negatives were included. Significantly increased risk of DENV-infection was observed 31–300 days post-COVID-19 (adjusted-hazards-ratio, aHR = 1.10[95%CI = 1.05–1.15]), during a DENV3 surge. Excess-burden of DENV-infection post-COVID-19 was 0.36 cases (95%CI = 0.11–0.61) per-1000-individuals. Risks of subsequent DENV-infection were numerically highest in unvaccinated COVID-19 cases but not elevated in doubly-boosted cases (≥4 vaccine-doses). Risk of negative-outcome controls (other-infections) was not significantly elevated 31–300 days post-COVID-19, and risk of DENV-infection was not significantly elevated post-influenza vaccination.

Interpretation

Increased risk of DENV-infection (primarily DENV3) was observed up to 300 days post-SARS-CoV-2 infection (predominantly Omicron). While not irrefutable proof for possible antibody-dependent enhancement of DENV3-infection post-Omicron COVID-19, given modest effect sizes, future studies can shed more light on potential interactions. Public health strategies (e.g., vaccination) remain important in tropical/subtropical regions where COVID-19/DENV are now endemic.

Funding

National-Medical-Research-Council, Singapore.
登革热病毒感染和SARS-CoV-2目前在热带地区流行;由于抗原的交叉反应性和交叉保护,可能存在相互作用。在以人群为基础的成人队列中评估先前COVID-19后继发denv感染的风险。方法回顾性队列研究,纳入所有≥18岁的新加坡人。使用国家登记处构建2021年9月1日至2022年12月31日期间Delta/Omicron出现期间的同期sars - cov -2感染/检测阴性队列。使用国家免疫登记系统对COVID-19疫苗接种状况进行分类。使用重叠加权Cox回归将covid -19后31-300天国家登记处记录的denv感染风险与检测阴性进行对比。其他感染(侵袭性肺炎球菌病/结核病/类鼻疽病/钩端螺旋体病)的风险被评估为阴性结果对照,流感疫苗接种后denv感染的风险被评估为阴性暴露对照。结果包括1324250例COVID-19病例(主要是疫苗突破的轻度欧米克隆感染)和1434851例检测阴性。在covid -19后31-300天,denv感染风险显著增加(校正危险比,aHR = 1.10[95%CI = 1.05-1.15])。covid -19后denv感染的额外负担为每1000人0.36例(95%CI = 0.11-0.61)。在未接种疫苗的COVID-19病例中,随后denv感染的风险在数字上最高,但在双强化病例(≥4剂疫苗)中没有升高。阴性结果对照(其他感染)的风险在covid -19后31-300天没有显著升高,流感疫苗接种后denv感染的风险没有显著升高。在sars - cov -2感染(主要是欧米克隆)后300天内观察到denv感染(主要是DENV3)的风险增加。虽然没有无可辩驳的证据表明,在omicron COVID-19后,denv3感染可能依赖抗体增强,但考虑到适度的效应规模,未来的研究可以更多地阐明潜在的相互作用。在目前流行COVID-19/DENV的热带/亚热带地区,公共卫生战略(例如疫苗接种)仍然很重要。FundingNational-Medical-Research-Council,新加坡。
{"title":"Risk of dengue following prior SARS-CoV-2 infection: a population-based cohort study","authors":"Liang En Wee ,&nbsp;Jue Tao Lim ,&nbsp;An Ting Tay ,&nbsp;Borame Dickens ,&nbsp;Pei Ma ,&nbsp;Calvin Chiew ,&nbsp;Po Ying Chia ,&nbsp;Yee Sin Leo ,&nbsp;Lee Ching Ng ,&nbsp;David Chien Lye ,&nbsp;Kelvin Bryan Tan","doi":"10.1016/j.lanwpc.2025.101727","DOIUrl":"10.1016/j.lanwpc.2025.101727","url":null,"abstract":"<div><h3>Background</h3><div>DENV-infection and SARS-CoV-2 are now endemic in tropical regions; interactions may exist, given antigenic cross-reactivity and cross-protection. Risk of subsequent DENV-infection following prior COVID-19 was evaluated in a population-based adult cohort.</div></div><div><h3>Methods</h3><div>Retrospective cohort study including all Singaporeans ≥18 years. National registries were used to construct contemporaneous SARS-CoV-2-infected/test-negative cohorts from 1st Sept 2021–31st Dec 2022 during Delta/Omicron emergence. COVID-19 vaccination status was classified using the national-immunization-registry. Risk of DENV-infection recorded in the national registry 31–300 days post-COVID-19 was contrasted against test-negatives using overlap-weighted Cox regression. Risk of other infections (invasive-pneumococcal-disease/tuberculosis/melioidosis/leptospirosis) were assessed as negative-outcome controls, and risk of DENV-infection post-influenza vaccination was assessed as a negative-exposure control.</div></div><div><h3>Findings</h3><div>1,324,250 COVID-19 cases (predominantly vaccine-breakthrough mild Omicron infections) and 1,434,851 test-negatives were included. Significantly increased risk of DENV-infection was observed 31–300 days post-COVID-19 (adjusted-hazards-ratio, aHR = 1.10[95%CI = 1.05–1.15]), during a DENV3 surge. Excess-burden of DENV-infection post-COVID-19 was 0.36 cases (95%CI = 0.11–0.61) per-1000-individuals. Risks of subsequent DENV-infection were numerically highest in unvaccinated COVID-19 cases but not elevated in doubly-boosted cases (≥4 vaccine-doses). Risk of negative-outcome controls (other-infections) was not significantly elevated 31–300 days post-COVID-19, and risk of DENV-infection was not significantly elevated post-influenza vaccination.</div></div><div><h3>Interpretation</h3><div>Increased risk of DENV-infection (primarily DENV3) was observed up to 300 days post-SARS-CoV-2 infection (predominantly Omicron). While not irrefutable proof for possible antibody-dependent enhancement of DENV3-infection post-Omicron COVID-19, given modest effect sizes, future studies can shed more light on potential interactions. Public health strategies (e.g., vaccination) remain important in tropical/subtropical regions where COVID-19/DENV are now endemic.</div></div><div><h3>Funding</h3><div><span>National-Medical-Research-Council</span>, Singapore.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"64 ","pages":"Article 101727"},"PeriodicalIF":8.1,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145466901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Screening and diagnostic strategies for active pulmonary tuberculosis among people in prison in Malaysia: a prospective diagnostic study 马来西亚监狱中活动性肺结核的筛查和诊断策略:一项前瞻性诊断研究
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-01 DOI: 10.1016/j.lanwpc.2025.101712
Lu Zhang , Frederick L. Altice , Adeeba Kamarulzaman , Ahsan Ahmad , Sangeeth Kaur , Saidatul Hanida Mohd Yukhi , Nor Akma Ibrahim , J. Lucian Davis , Zailiza bt Suli , Sheela V. Shenoi

Background

The World Health Organization (WHO) recommends tuberculosis (TB) screening in prisons but data on specific strategies are lacking.

Methods

Men sequentially entering Kajang Prison, Malaysia's largest prison, underwent standardized WHO symptom screening (SS), chest X-ray (CXR), and c-reactive protein (CRP ≥5 mg/L) screening tests while acid-fast bacilli (AFB) smears and Xpert were diagnostic tests. The reference standard was culture. We defined three screening strategies and compared their sensitivity, specificity, positive predictive value, negative predictive value, receiver operator curves, and area under the curve (AUC).

Findings

We enrolled 588 people in prison, mean age 43 (range: 21–68) years, 60 (10.2%) with HIV, 493 (83.8%) with opioid use disorder, and 265 (45.1%) with HCV. Among these, 34 (5.8%) were diagnosed with culture-positive active pulmonary TB (PTB). For screening, the sensitivity of SS, CRP ≥5 mg/L, and CXR demonstrating PTB was 38.2% (95% CI 22.2–56.4), 47.1% (95% CI 29.8–64.9), and 91.2% (95% CI 76.3–98.1). Among people without HIV, “SS-CXR” had the highest AUC (74.7% [95% CI 68.6–80.7]). For people with HIV, however, “SS-CRP” had the highest AUC (85.5% [95% CI 79.4–91.5]). For diagnosis, Xpert had a higher sensitivity (82.4% [95% CI 65.5–93.2] and specificity (95.5% [95% CI 93.4–97.1]) than AFB smear. Compared to “SS-Xpert”, both “SS-CXR-Xpert” and “SS-CRP-Xpert” had a significantly higher AUC in people without HIV (84.2% p < 0.0001 and 72.9% p = 0.023, respectively) and people with HIV (87.3% p = 0.022 and 88.2% p = 0.018, respectively).

Interpretation

Among people in prison, adding CXR or CRP to symptom screen was more effective than symptom screen alone. In addition to symptom screen, CRP performed better than CXR among people with HIV while CXR was more valuable than CRP among people without HIV.

Funding

U.S. National Institute on Drug Abuse.
背景:世界卫生组织(世卫组织)建议在监狱中进行结核病筛查,但缺乏具体策略的数据。方法对进入马来西亚最大监狱加jang监狱的囚犯进行标准化的WHO症状筛查(SS)、胸部x线检查(CXR)和c反应蛋白(CRP≥5 mg/L)筛查试验,同时对抗酸杆菌(AFB)涂片和Xpert进行诊断试验。参照标准为培养物。我们定义了三种筛查策略,并比较了它们的敏感性、特异性、阳性预测值、阴性预测值、接受者操作曲线和曲线下面积(AUC)。研究结果:我们招募了588名囚犯,平均年龄43岁(范围:21-68岁),60人(10.2%)患有艾滋病,493人(83.8%)患有阿片类药物使用障碍,265人(45.1%)患有丙型肝炎。其中34例(5.8%)被诊断为培养阳性活动性肺结核(PTB)。筛查时,SS、CRP≥5mg /L和CXR显示PTB的敏感性分别为38.2% (95% CI 22.2-56.4)、47.1% (95% CI 29.8-64.9)和91.2% (95% CI 76.3-98.1)。在未感染HIV的人群中,“SS-CXR”的AUC最高(74.7% [95% CI 68.6-80.7])。然而,对于HIV感染者,“SS-CRP”的AUC最高(85.5% [95% CI 79.4-91.5])。对于诊断,Xpert比AFB涂片具有更高的敏感性(82.4% [95% CI 65.5-93.2]和特异性(95.5% [95% CI 93.4-97.1])。与“SS-Xpert”相比,“SS-CXR-Xpert”和“SS-CRP-Xpert”在未感染HIV(分别为84.2% p <; 0.0001和72.9% p = 0.023)和感染HIV(分别为87.3% p = 0.022和88.2% p = 0.018)的人群中的AUC均显著高于“SS-Xpert”。在监狱服刑人员中,在症状筛查中加入CXR或CRP比单独进行症状筛查更有效。除了症状筛查外,CRP在HIV感染者中的表现优于CXR,而在非HIV感染者中,CXR比CRP更有价值。国家药物滥用研究所。
{"title":"Screening and diagnostic strategies for active pulmonary tuberculosis among people in prison in Malaysia: a prospective diagnostic study","authors":"Lu Zhang ,&nbsp;Frederick L. Altice ,&nbsp;Adeeba Kamarulzaman ,&nbsp;Ahsan Ahmad ,&nbsp;Sangeeth Kaur ,&nbsp;Saidatul Hanida Mohd Yukhi ,&nbsp;Nor Akma Ibrahim ,&nbsp;J. Lucian Davis ,&nbsp;Zailiza bt Suli ,&nbsp;Sheela V. Shenoi","doi":"10.1016/j.lanwpc.2025.101712","DOIUrl":"10.1016/j.lanwpc.2025.101712","url":null,"abstract":"<div><h3>Background</h3><div>The World Health Organization (WHO) recommends tuberculosis (TB) screening in prisons but data on specific strategies are lacking.</div></div><div><h3>Methods</h3><div>Men sequentially entering Kajang Prison, Malaysia's largest prison, underwent standardized WHO symptom screening (SS), chest X-ray (CXR), and c-reactive protein (CRP ≥5 mg/L) screening tests while acid-fast bacilli (AFB) smears and Xpert were diagnostic tests. The reference standard was culture. We defined three screening strategies and compared their sensitivity, specificity, positive predictive value, negative predictive value, receiver operator curves, and area under the curve (AUC).</div></div><div><h3>Findings</h3><div>We enrolled 588 people in prison, mean age 43 (range: 21–68) years, 60 (10.2%) with HIV, 493 (83.8%) with opioid use disorder, and 265 (45.1%) with HCV. Among these, 34 (5.8%) were diagnosed with culture-positive active pulmonary TB (PTB). For screening, the sensitivity of SS, CRP ≥5 mg/L, and CXR demonstrating PTB was 38.2% (95% CI 22.2–56.4), 47.1% (95% CI 29.8–64.9), and 91.2% (95% CI 76.3–98.1). Among people without HIV, “SS-CXR” had the highest AUC (74.7% [95% CI 68.6–80.7]). For people with HIV, however, “SS-CRP” had the highest AUC (85.5% [95% CI 79.4–91.5]). For diagnosis, Xpert had a higher sensitivity (82.4% [95% CI 65.5–93.2] and specificity (95.5% [95% CI 93.4–97.1]) than AFB smear. Compared to “SS-Xpert”, both “SS-CXR-Xpert” and “SS-CRP-Xpert” had a significantly higher AUC in people without HIV (84.2% p &lt; 0.0001 and 72.9% p = 0.023, respectively) and people with HIV (87.3% p = 0.022 and 88.2% p = 0.018, respectively).</div></div><div><h3>Interpretation</h3><div>Among people in prison, adding CXR or CRP to symptom screen was more effective than symptom screen alone. In addition to symptom screen, CRP performed better than CXR among people with HIV while CXR was more valuable than CRP among people without HIV.</div></div><div><h3>Funding</h3><div>U.S. <span>National Institute on Drug Abuse</span>.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"64 ","pages":"Article 101712"},"PeriodicalIF":8.1,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145517452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiological analysis of infectious diseases in older people in China from 2014 to 2022: a population-based study 2014 - 2022年中国老年人传染病流行病学分析:基于人群的研究
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-01 DOI: 10.1016/j.lanwpc.2025.101729
Sheng-Hong Lin , Chen-Long Lv , Meng-Jie Geng , Rui-Cheng Gao , Yan-Qun Sun , Yan-He Wang , Ya-Ming Zheng , Tian Tang , Chun-Xi Shan , Yao Tian , Yun-Bo Qiu , Jun Ma , Yan Zhang , Yu-Feng Yang , Qiang Xu , Guo-Lin Wang , Yan-Ping Zhang , Qun Li , Li-Ping Wang , Peng-Tao Bao , Wei Liu

Background

The whole world is undergoing an unprecedented rapid population aging, and the accompanying threat of infectious diseases epidemic among the older people will pose a serious challenge to the national public health.

Methods

We extracted individual data on 21 notifiable infectious diseases (NIDs) among individuals aged ≥60 years from the Chinese Infectious Disease Surveillance and Control Project (CISDCP) from 2014 to 2022 in the mainland of China. We comprehensively analyzed the epidemiological characteristics of NIDs in older people and estimated the impact of age, year, and the COVID-19 pandemic.

Findings

A total of 8,604,064 cases of 21 major NIDs were reported, with an overall annual incidence of 362·10/100,000. Sexually transmitted or bloodborne diseases (STBDs, 45·23%) were the most common diseases. Notably, ranking of syphilis rose from fourth to third, while HIV/AIDS moved from eighth to seventh; respiratory diseases (34·88%) showed sustained declines. Tuberculosis remained the most common respiratory diseases despite a 6·4% annual decline (APC, P < 0·001); gastrointestinal or enteroviral diseases (GEDs, 18·35%) showed sustained declines, except for infectious diarrhea and hepatitis E; vector-borne or zoonotic diseases (VBZDs, 1·54%) remained low, though brucellosis increased during COVID-19 pandemic. Inflection point analysis revealed that 13 diseases, such as tuberculosis, infectious diarrhea, hepatitis B, and others, exhibited a quadratic distribution (inverted “V” shape) in age-specific incidence as age increased. Difference was noticeable between regions, with the older people in Inner Mongolia-Xinjiang region and South China region continuing to carry a disproportionate burden from NIDs.

Interpretation

Although China's success in infectious disease control in older people. Effective prevention and control strategies are needed for highest incidence diseases, such as tuberculosis, hepatitis B, and infectious diarrhea, especially in high-incidence regions and among critical age points.

Funding

National Major Research & Development Program of China (2022YFC2604000).
全球正处于前所未有的人口快速老龄化时期,伴随而来的老年人传染病流行威胁将对国家公共卫生构成严峻挑战。方法提取2014 - 2022年中国传染病监测与控制项目(CISDCP)中年龄≥60岁人群中21种法定传染病(NIDs)的个体数据。我们综合分析了老年人NIDs的流行病学特征,并估计了年龄、年份和COVID-19大流行的影响。结果21种主要NIDs共报告8604064例,年总发病率为362·10/10万。性传播或血源性疾病(STBDs, 45.23%)是最常见的疾病。值得注意的是,梅毒的排名从第四位上升到第三位,而艾滋病毒/艾滋病从第八位上升到第七位;呼吸系统疾病(34.88%)持续下降。结核病仍然是最常见的呼吸道疾病,尽管每年下降6.4% (APC, P < 0.001);除感染性腹泻和戊型肝炎外,胃肠道或肠病毒疾病(GEDs, 18.35%)持续下降;病媒传播或人畜共患疾病(VBZDs, 1.54%)保持在较低水平,但在COVID-19大流行期间布鲁氏菌病有所增加。拐点分析显示,随着年龄的增长,结核病、传染性腹泻、乙型肝炎等13种疾病的年龄特异性发病率呈二次型分布(倒“V”形)。不同地区之间的差异是明显的,内蒙古-新疆地区和华南地区的老年人继续承担着不成比例的NIDs负担。虽然中国在老年人传染病控制方面取得了成功。对于结核病、乙型肝炎和传染性腹泻等发病率最高的疾病,特别是在高发病率地区和关键年龄点,需要有效的预防和控制战略。国家重大研究发展计划项目(2022YFC2604000)。
{"title":"Epidemiological analysis of infectious diseases in older people in China from 2014 to 2022: a population-based study","authors":"Sheng-Hong Lin ,&nbsp;Chen-Long Lv ,&nbsp;Meng-Jie Geng ,&nbsp;Rui-Cheng Gao ,&nbsp;Yan-Qun Sun ,&nbsp;Yan-He Wang ,&nbsp;Ya-Ming Zheng ,&nbsp;Tian Tang ,&nbsp;Chun-Xi Shan ,&nbsp;Yao Tian ,&nbsp;Yun-Bo Qiu ,&nbsp;Jun Ma ,&nbsp;Yan Zhang ,&nbsp;Yu-Feng Yang ,&nbsp;Qiang Xu ,&nbsp;Guo-Lin Wang ,&nbsp;Yan-Ping Zhang ,&nbsp;Qun Li ,&nbsp;Li-Ping Wang ,&nbsp;Peng-Tao Bao ,&nbsp;Wei Liu","doi":"10.1016/j.lanwpc.2025.101729","DOIUrl":"10.1016/j.lanwpc.2025.101729","url":null,"abstract":"<div><h3>Background</h3><div>The whole world is undergoing an unprecedented rapid population aging, and the accompanying threat of infectious diseases epidemic among the older people will pose a serious challenge to the national public health.</div></div><div><h3>Methods</h3><div>We extracted individual data on 21 notifiable infectious diseases (NIDs) among individuals aged ≥60 years from the Chinese Infectious Disease Surveillance and Control Project (CISDCP) from 2014 to 2022 in the mainland of China. We comprehensively analyzed the epidemiological characteristics of NIDs in older people and estimated the impact of age, year, and the COVID-19 pandemic.</div></div><div><h3>Findings</h3><div>A total of 8,604,064 cases of 21 major NIDs were reported, with an overall annual incidence of 362·10/100,000. Sexually transmitted or bloodborne diseases (STBDs, 45·23%) were the most common diseases. Notably, ranking of syphilis rose from fourth to third, while HIV/AIDS moved from eighth to seventh; respiratory diseases (34·88%) showed sustained declines. Tuberculosis remained the most common respiratory diseases despite a 6·4% annual decline (APC, P &lt; 0·001); gastrointestinal or enteroviral diseases (GEDs, 18·35%) showed sustained declines, except for infectious diarrhea and hepatitis E; vector-borne or zoonotic diseases (VBZDs, 1·54%) remained low, though brucellosis increased during COVID-19 pandemic. Inflection point analysis revealed that 13 diseases, such as tuberculosis, infectious diarrhea, hepatitis B, and others, exhibited a quadratic distribution (inverted “V” shape) in age-specific incidence as age increased. Difference was noticeable between regions, with the older people in Inner Mongolia-Xinjiang region and South China region continuing to carry a disproportionate burden from NIDs.</div></div><div><h3>Interpretation</h3><div>Although China's success in infectious disease control in older people. Effective prevention and control strategies are needed for highest incidence diseases, such as tuberculosis, hepatitis B, and infectious diarrhea, especially in high-incidence regions and among critical age points.</div></div><div><h3>Funding</h3><div><span>National Major Research</span> &amp; <span>Development Program of China</span> (<span><span>2022YFC2604000</span></span>).</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"64 ","pages":"Article 101729"},"PeriodicalIF":8.1,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145466900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exclusionary election rhetoric and its impact on migrant health research in Japan 排他性选举言论及其对日本移民健康研究的影响
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-01 DOI: 10.1016/j.lanwpc.2025.101740
Tadashi Yamashita , Akihito Uezato
{"title":"Exclusionary election rhetoric and its impact on migrant health research in Japan","authors":"Tadashi Yamashita ,&nbsp;Akihito Uezato","doi":"10.1016/j.lanwpc.2025.101740","DOIUrl":"10.1016/j.lanwpc.2025.101740","url":null,"abstract":"","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"64 ","pages":"Article 101740"},"PeriodicalIF":8.1,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145467662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adverse health outcomes among migrant workers and transnational families in the Asia–Pacific: a systematic review and meta-analysis 亚太地区移民工人和跨国家庭的不良健康结果:系统回顾和荟萃分析
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-01 DOI: 10.1016/j.lanwpc.2025.101720
Rosita Chia-Yin Lin , Karen Lau , Kathryn Mackey , Natasha Roya Matthews , Maushmi Selvamani , Morais Beatriz , Bouaddi Oumnia , Chaelin Kim , Azusa Iwamoto , Masami Fujita , Ursula Trummer , Tran Ngoc Dang , Alena Kamenshchikova , Cathy Zimmerman , Sally Hargreaves
<div><h3>Background</h3><div>Labour migration is a growing global phenomenon, with migrant workers known to be more likely to experience exploitative and precarious work, impacting their health. Despite hosting over 27 million international migrant workers, the Asia–Pacific region remains underrepresented in global health evidence, limiting the development of targeted, region-specific health interventions. This study aims to investigate the health status of migrant workers and their transnational families in the Asia–Pacific region.</div></div><div><h3>Methods</h3><div>We conducted a systematic review and meta-analysis (PROSPERO: CRD42024528561) of primary studies published between Jan 1, 2013, and April 1, 2024. We searched MEDLINE, Embase, PsycINFO, and Ovid Global Health for studies reporting work-related morbidity and mortality among international migrant workers and their transnational families in the Asia–Pacific region. A narrative synthesis identified occupational risks; a meta-analysis estimated pooled prevalence of morbidity among migrant workers and relative risks compared to local workers.</div></div><div><h3>Findings</h3><div>Of 2877 studies identified, 54 met inclusion criteria, including 38 eligible for meta-analysis, encompassing 86,620 individuals across 17 Asia–Pacific countries. Among migrant workers (n = 64,172), 88.4% experienced occupational injuries and illnesses including work-related injuries, pesticide poisoning symptoms and respiratory diseases (n = 45,661), with 75% of migrant workers in this large dataset working in high-risk sectors such as manufacturing, construction, and services (including drivers and restaurant workers). 3.8% reported symptoms of mental health disorders such as anxiety and depression (n = 1975), and 3.8% had musculoskeletal disorders (n = 1973). The pooled prevalence of at least one work-related morbidity was 37% (95% CI: 27–47; <em>I</em><sup><em>2</em></sup> = 99.0%), with a pooled relative risk of 1.29 (95% CI: 1.10–1.52; <em>I</em><sup><em>2</em></sup> = 47.4%) compared with local workers. Among transnational families left behind in the migrant worker's country of origin (n = 22,448), 50.1% reported mental health issues (n = 1520), and 31.4% experienced undernutrition (n = 954). Key contributing factors to poor health outcomes of migrant workers included long working hours, workplace hazards, precarious working conditions, and healthcare access barriers.</div></div><div><h3>Interpretation</h3><div>Migrant workers in the Asia–Pacific face substantial risks of a wide range of occupational injuries and illnesses. Although some studies support the “healthy migrant effect,” this advantage clearly diminishes over time due to cumulative exposure to occupational and structural stressors. Strengthening occupational safety, regulating working hours, and improving healthcare access, are urgent priorities for countries hosting large migrant worker populations and employers of migrant workers.</div></div>
劳动力移徙是一种日益严重的全球现象,众所周知,移徙工人更有可能从事剥削性和不稳定的工作,从而影响他们的健康。尽管亚太地区接待了2 700多万国际移徙工人,但在全球卫生证据中,亚太地区的代表性仍然不足,限制了有针对性的区域卫生干预措施的发展。本研究旨在调查亚太地区外来务工人员及其跨国家庭的健康状况。方法:我们对2013年1月1日至2024年4月1日发表的主要研究进行了系统回顾和荟萃分析(PROSPERO: CRD42024528561)。我们检索了MEDLINE、Embase、PsycINFO和Ovid Global Health,以获取报告亚太地区国际移民工人及其跨国家庭与工作相关的发病率和死亡率的研究。叙述综合确定了职业风险;一项荟萃分析估计了移民工人的发病率和与当地工人相比的相对风险。在2877项研究中,54项符合纳入标准,其中38项符合荟萃分析的条件,涵盖了17个亚太国家的86620人。在农民工(n = 64,172)中,88.4%经历过职业伤害和疾病,包括工伤、农药中毒症状和呼吸系统疾病(n = 45,661),该大型数据集中75%的农民工在制造业、建筑业和服务业(包括司机和餐馆工人)等高风险部门工作。3.8%报告有焦虑和抑郁等精神健康障碍症状(n = 1975), 3.8%有肌肉骨骼疾病(n = 1973)。与当地工人相比,至少有一种工作相关疾病的总患病率为37% (95% CI: 27-47; I2 = 99.0%),总相对危险度为1.29 (95% CI: 1.10-1.52; I2 = 47.4%)。在留在移徙工人原籍国的跨国家庭中(n = 22,448), 50.1%报告了精神健康问题(n = 1520), 31.4%报告了营养不良(n = 954)。造成移徙工人健康状况不佳的主要因素包括工作时间长、工作场所危险、不稳定的工作条件和获得医疗保健的障碍。亚太地区的移民工人面临着各种职业伤害和疾病的巨大风险。尽管一些研究支持“健康移民效应”,但由于长期暴露于职业和结构压力源,这种优势显然会随着时间的推移而减弱。加强职业安全、规范工作时间和改善医疗保健可及性,是收容大量移徙工人的国家和移徙工人雇主的紧迫优先事项。台湾教育部资助;惠康信托(318501/Z/24/Z和335954/Z/25/Z);联合王国医学研究理事会(MR/W006677/1);英国国家卫生保健研究所(NIHR209895);“la Caixa”基金会(LCF/PR/SP21/52930003)。
{"title":"Adverse health outcomes among migrant workers and transnational families in the Asia–Pacific: a systematic review and meta-analysis","authors":"Rosita Chia-Yin Lin ,&nbsp;Karen Lau ,&nbsp;Kathryn Mackey ,&nbsp;Natasha Roya Matthews ,&nbsp;Maushmi Selvamani ,&nbsp;Morais Beatriz ,&nbsp;Bouaddi Oumnia ,&nbsp;Chaelin Kim ,&nbsp;Azusa Iwamoto ,&nbsp;Masami Fujita ,&nbsp;Ursula Trummer ,&nbsp;Tran Ngoc Dang ,&nbsp;Alena Kamenshchikova ,&nbsp;Cathy Zimmerman ,&nbsp;Sally Hargreaves","doi":"10.1016/j.lanwpc.2025.101720","DOIUrl":"10.1016/j.lanwpc.2025.101720","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;div&gt;Labour migration is a growing global phenomenon, with migrant workers known to be more likely to experience exploitative and precarious work, impacting their health. Despite hosting over 27 million international migrant workers, the Asia–Pacific region remains underrepresented in global health evidence, limiting the development of targeted, region-specific health interventions. This study aims to investigate the health status of migrant workers and their transnational families in the Asia–Pacific region.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;We conducted a systematic review and meta-analysis (PROSPERO: CRD42024528561) of primary studies published between Jan 1, 2013, and April 1, 2024. We searched MEDLINE, Embase, PsycINFO, and Ovid Global Health for studies reporting work-related morbidity and mortality among international migrant workers and their transnational families in the Asia–Pacific region. A narrative synthesis identified occupational risks; a meta-analysis estimated pooled prevalence of morbidity among migrant workers and relative risks compared to local workers.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Findings&lt;/h3&gt;&lt;div&gt;Of 2877 studies identified, 54 met inclusion criteria, including 38 eligible for meta-analysis, encompassing 86,620 individuals across 17 Asia–Pacific countries. Among migrant workers (n = 64,172), 88.4% experienced occupational injuries and illnesses including work-related injuries, pesticide poisoning symptoms and respiratory diseases (n = 45,661), with 75% of migrant workers in this large dataset working in high-risk sectors such as manufacturing, construction, and services (including drivers and restaurant workers). 3.8% reported symptoms of mental health disorders such as anxiety and depression (n = 1975), and 3.8% had musculoskeletal disorders (n = 1973). The pooled prevalence of at least one work-related morbidity was 37% (95% CI: 27–47; &lt;em&gt;I&lt;/em&gt;&lt;sup&gt;&lt;em&gt;2&lt;/em&gt;&lt;/sup&gt; = 99.0%), with a pooled relative risk of 1.29 (95% CI: 1.10–1.52; &lt;em&gt;I&lt;/em&gt;&lt;sup&gt;&lt;em&gt;2&lt;/em&gt;&lt;/sup&gt; = 47.4%) compared with local workers. Among transnational families left behind in the migrant worker's country of origin (n = 22,448), 50.1% reported mental health issues (n = 1520), and 31.4% experienced undernutrition (n = 954). Key contributing factors to poor health outcomes of migrant workers included long working hours, workplace hazards, precarious working conditions, and healthcare access barriers.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Interpretation&lt;/h3&gt;&lt;div&gt;Migrant workers in the Asia–Pacific face substantial risks of a wide range of occupational injuries and illnesses. Although some studies support the “healthy migrant effect,” this advantage clearly diminishes over time due to cumulative exposure to occupational and structural stressors. Strengthening occupational safety, regulating working hours, and improving healthcare access, are urgent priorities for countries hosting large migrant worker populations and employers of migrant workers.&lt;/div&gt;&lt;/div&gt;","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"64 ","pages":"Article 101720"},"PeriodicalIF":8.1,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145419429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiometabolic health and risk of dementia and brain atrophy: a community-based prospective cohort study of 0.5 million adults in China 心血管代谢健康与痴呆和脑萎缩风险:中国50万成年人的社区前瞻性队列研究
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-01 DOI: 10.1016/j.lanwpc.2025.101743
Clara Bueno Lopez , Andri Iona , Daniel Avery , Iain Turnbull , Ling Yang , Huaidong Du , Yiping Chen , Ningmei Zhang , Junshi Chen , Pei Pei , Jun Lv , Canquing Yu , Dianjianyi Sun , Liming Li , Derrick Bennett , Cornelia van Dujin , Robert Clarke , Zhengming Chen , Fiona Bragg , China Kadoorie Biobank Collaborative Group

Background

Cardiometabolic health has been associated with dementia risk but prospective evidence is limited in China where the burden of cardiometabolic disease and dementia are rising. We investigate the relevance of markers of cardiometabolic health for risk of dementia and brain atrophy.

Methods

China Kadoorie Biobank is a prospective cohort study involving 512,724 adults aged 30–79 years, recruited in 2004–2008 from 10 diverse regions. During ∼12 years’ follow-up, 1099 dementia and 1418 brain atrophy cases were recorded through linked death registries and health insurance databases. Cox regression yield adjusted hazard ratios (HRs) for incident dementia and brain atrophy associated with markers of cardiometabolic health.

Findings

The incidence rate for dementia and brain atrophy was 19.0 and 25.4 per 100,000 person-years, respectively, higher at older ages, and among males. Prior hypertension (adjusted HR 1.21 [95% CI 1.05–1.39]), diabetes (1.36 [1.13–1.65]) and stroke (2.52 [2.14–2.96]) were associated with higher risks of dementia and brain atrophy (1.30 [1.15–1.47], 1.32 [1.12–1.55], 2.43 [2.12–2.78], respectively). Prior IHD was associated with brain atrophy (1.69 [1.47–1.95]), but not dementia (1.17 [0.97–1.41]).

Interpretation

These findings provide evidence of the relevance of markers of cardiometabolic health for dementia among adults in China, highlighting the importance of preventative strategies for cardiometabolic diseases that may lead to benefits for brain health.

Funding

Wellcome Trust, MRC, BHF, CR-UK, Kadoorie Charitable Foundation, Chinese MoST and NSFC.
背景:心脏代谢健康与痴呆风险相关,但在心脏代谢疾病和痴呆负担不断增加的中国,前瞻性证据有限。我们研究了心脏代谢健康标志物与痴呆和脑萎缩风险的相关性。方法中国嘉道理生物库是一项前瞻性队列研究,涉及2004-2008年从10个不同地区招募的512,724名年龄在30-79岁之间的成年人。在12年的随访期间,通过相关的死亡登记和健康保险数据库记录了1099例痴呆和1418例脑萎缩病例。Cox回归产生与心脏代谢健康标志物相关的痴呆和脑萎缩事件的校正风险比(hr)。研究发现,痴呆和脑萎缩的发病率分别为19.0 / 10万人/年和25.4 / 10万人/年,老年人和男性的发病率更高。既往高血压(校正HR 1.21 [95% CI 1.05-1.39])、糖尿病(1.36[1.13-1.65])和中风(2.52[2.14-2.96])与痴呆和脑萎缩的高风险相关(分别为1.30[1.15-1.47]、1.32[1.12-1.55]、2.43[2.12-2.78])。先前的IHD与脑萎缩相关(1.69[1.47-1.95]),但与痴呆无关(1.17[0.97-1.41])。这些研究结果为中国成人痴呆症的心脏代谢健康标志物的相关性提供了证据,强调了心脏代谢疾病预防策略的重要性,这可能会对大脑健康有益。资助:惠康信托、MRC、BHF、CR-UK、嘉道理慈善基金会、中国科技部及国家自然科学基金委员会。
{"title":"Cardiometabolic health and risk of dementia and brain atrophy: a community-based prospective cohort study of 0.5 million adults in China","authors":"Clara Bueno Lopez ,&nbsp;Andri Iona ,&nbsp;Daniel Avery ,&nbsp;Iain Turnbull ,&nbsp;Ling Yang ,&nbsp;Huaidong Du ,&nbsp;Yiping Chen ,&nbsp;Ningmei Zhang ,&nbsp;Junshi Chen ,&nbsp;Pei Pei ,&nbsp;Jun Lv ,&nbsp;Canquing Yu ,&nbsp;Dianjianyi Sun ,&nbsp;Liming Li ,&nbsp;Derrick Bennett ,&nbsp;Cornelia van Dujin ,&nbsp;Robert Clarke ,&nbsp;Zhengming Chen ,&nbsp;Fiona Bragg ,&nbsp;China Kadoorie Biobank Collaborative Group","doi":"10.1016/j.lanwpc.2025.101743","DOIUrl":"10.1016/j.lanwpc.2025.101743","url":null,"abstract":"<div><h3>Background</h3><div>Cardiometabolic health has been associated with dementia risk but prospective evidence is limited in China where the burden of cardiometabolic disease and dementia are rising. We investigate the relevance of markers of cardiometabolic health for risk of dementia and brain atrophy.</div></div><div><h3>Methods</h3><div>China Kadoorie Biobank is a prospective cohort study involving 512,724 adults aged 30–79 years, recruited in 2004–2008 from 10 diverse regions. During ∼12 years’ follow-up, 1099 dementia and 1418 brain atrophy cases were recorded through linked death registries and health insurance databases. Cox regression yield adjusted hazard ratios (HRs) for incident dementia and brain atrophy associated with markers of cardiometabolic health.</div></div><div><h3>Findings</h3><div>The incidence rate for dementia and brain atrophy was 19.0 and 25.4 per 100,000 person-years, respectively, higher at older ages, and among males. Prior hypertension (adjusted HR 1.21 [95% CI 1.05–1.39]), diabetes (1.36 [1.13–1.65]) and stroke (2.52 [2.14–2.96]) were associated with higher risks of dementia and brain atrophy (1.30 [1.15–1.47], 1.32 [1.12–1.55], 2.43 [2.12–2.78], respectively). Prior IHD was associated with brain atrophy (1.69 [1.47–1.95]), but not dementia (1.17 [0.97–1.41]).</div></div><div><h3>Interpretation</h3><div>These findings provide evidence of the relevance of markers of cardiometabolic health for dementia among adults in China, highlighting the importance of preventative strategies for cardiometabolic diseases that may lead to benefits for brain health.</div></div><div><h3>Funding</h3><div><span>Wellcome Trust</span>, <span>MRC</span>, <span>BHF</span>, CR-UK, <span>Kadoorie Charitable Foundation</span>, Chinese MoST and NSFC.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"64 ","pages":"Article 101743"},"PeriodicalIF":8.1,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145569019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and associated factors of obesity, hypertension, and diabetes in French Polynesia: results from a nationwide cross-sectional study 法属波利尼西亚肥胖、高血压和糖尿病的患病率及其相关因素:一项全国性横断面研究的结果
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-01 DOI: 10.1016/j.lanwpc.2025.101746
Martin Paries , Iotefa Teiti , Maite Aubry , Etienne Patin , Yoann Madec , Kiyojiken Chung , Pauline Boucheron , Stéphane Lastère , Maëlia Etoundi , Tuterarii Paoaafaite , Lisa Dian , Raphaëlle Bos , André Wattiaux , Caroline Michaux , Henri-Pierre Mallet , Lluis Quintana-Murci , Arnaud Fontanet , Van-Mai Cao-Lormeau
<div><h3>Background</h3><div>Non-communicable diseases (NCDs) represent a major global health challenge, particularly in the Pacific. This study assessed the prevalence and associated factors of obesity, hypertension, and diabetes among adults in French Polynesia.</div></div><div><h3>Methods</h3><div>A cross-sectional survey (2019–2021) was conducted on a nationally representative sample of adults across all five archipelagos (Tuamotu, Gambier, Marquesas, Austral, and Society including the Leeward and Windward Islands). Data included anthropometrics, blood pressure, biochemical markers (lipids, renal function), sociodemographic, lifestyle, and health history. NCDs were defined as hypertension (systolic BP >140 mmHg, diastolic BP >90 mmHg, and/or self-report of anti-hypertension medication use), diabetes (HbA1c >6·5%, and/or self-report of previous medical diagnosis), and obesity (using either BMI ≥30 kg/m<sup>2</sup> or a revised definition incorporating ethnicity-specific thresholds and additional anthropometric criteria).</div></div><div><h3>Findings</h3><div>A total of 1893 adults were included (987 women; 906 men). Among them, 669 (weighted prevalence: 35·5%, 95% CI: 33–38) had hypertension, 214 (weighted prevalence: 12·2%, 95% CI: 10–14) had diabetes (including 53 undiagnosed, weighted prevalence: 3·1%, 95% CI: 2–4), and 1022 (weighted prevalence: 51·1%, 95% CI: 48–54) or 847 (weighted prevalence: 42·7%, 95% CI: 40–46) were classified as obese, using BMI-based or revised definitions, respectively. Among those with revised obesity, 439 (weighted prevalence: 52·2%, 95% CI: 48–57) presented metabolic abnormalities typically associated with the condition, while 408 (weighted prevalence: 47·8%, 95% CI: 43–52) were metabolically healthy, a phenotype that declined with age.</div><div>Women were less likely than men to have hypertension (OR = 0·59, 95% CI: 0·45–0·78), but more likely to present BMI-based obesity (OR = 1·61, 95% CI: 1·23–2·11). Hypertension odds were higher in Leeward versus Windward Islands (OR = 1·61, 95% CI: 1·24–2·09). Revised obesity was associated with low fruit/vegetable intake (OR = 1·53, 95% CI: 1·13–2·09), high meat consumption (OR = 1·52, 95% CI: 1·10–2·10), high fish consumption (OR = 1·54, 95% CI: 1·10–2·16), and low physical activity (OR = 1·58, 95% CI: 1·15–2·15). Obesity increased the odds of diabetes (OR = 2·99, 95% CI: 1·97–4·53) and hypertension (OR = 2·38, 95% CI: 1·80–3·14). Lower odds of obesity were observed in self-declared Polynesians of mixed ancestry (OR = 0·64, 95% CI: 0·42–0·96) and European immigrants (OR = 0·21, 95% CI: 0·07–0·61), as well as lower odds of diabetes in European immigrants (OR = 0·04, 95% CI: 0·01–0·19) compared to self-identified Polynesians.</div></div><div><h3>Interpretation</h3><div>The high prevalence of obesity, a key driver of hypertension and diabetes, highlights the need for both population-wide prevention and targeted interventions across all archipelagos. Using standar
非传染性疾病是一项重大的全球卫生挑战,特别是在太平洋地区。本研究评估了法属波利尼西亚成年人中肥胖、高血压和糖尿病的患病率及其相关因素。方法对所有五个群岛(土阿莫土群岛、甘比尔群岛、马克萨斯群岛、奥斯特尔群岛和社会群岛,包括背风和迎风群岛)的全国代表性成年人样本进行了横断面调查(2019-2021年)。数据包括人体测量、血压、生化指标(血脂、肾功能)、社会人口统计学、生活方式和健康史。非传染性疾病被定义为高血压(收缩压140毫米汞柱,舒张压90毫米汞柱,和/或自我报告使用抗高血压药物),糖尿病(HbA1c 6.5%,和/或自我报告既往医学诊断),和肥胖(使用BMI≥30 kg/m2或修订定义,纳入种族特异性阈值和额外的人体测量标准)。研究结果共纳入1893名成年人(987名女性,906名男性)。其中,669人(加权患病率:35.5%,95% CI: 33-38)患有高血压,214人(加权患病率:12.2%,95% CI: 10-14)患有糖尿病(包括53人未确诊,加权患病率:3.1%,95% CI: 2-4), 1022人(加权患病率:51.1%,95% CI: 48-54)或847人(加权患病率:42.7%,95% CI: 40-46)分别根据基于bmi的定义或修订的定义被归类为肥胖。在修正型肥胖患者中,439人(加权患病率:52.2%,95% CI: 48-57)表现出与该疾病典型相关的代谢异常,而408人(加权患病率:47.8%,95% CI: 43-52)代谢健康,这种表型随着年龄的增长而下降。女性患高血压的可能性低于男性(OR = 0.59, 95% CI: 0.45 - 0.78),但更有可能出现基于bmi的肥胖(OR = 1.61, 95% CI: 1.23 - 2.11)。背风岛与迎风岛高血压的发生率较高(OR = 1.61, 95% CI: 1.24 - 2.09)。修正后的肥胖与低水果/蔬菜摄入量(OR = 1.53, 95% CI: 1.13 - 2.09)、高肉类摄入量(OR = 1.52, 95% CI: 1.10 - 2.10)、高鱼类摄入量(OR = 1.54, 95% CI: 1.10 - 2.16)和低体力活动(OR = 1.58, 95% CI: 1.15 - 2.15)相关。肥胖增加了糖尿病(OR = 2.99, 95% CI: 1.97 - 4.53)和高血压(OR = 2.38, 95% CI: 1.80 - 3.14)的发生率。自认为是混合血统的波利尼西亚人(OR = 0.64, 95% CI: 0.42 - 0.96)和欧洲移民(OR = 0.21, 95% CI: 0.07 - 0.61)患肥胖症的几率较低,与自认为是波利尼西亚人相比,欧洲移民患糖尿病的几率较低(OR = 0.04, 95% CI: 0.01 - 0.19)。肥胖症的高患病率是高血压和糖尿病的主要驱动因素,这突出表明需要在所有群岛进行全民预防和有针对性的干预。使用标准指标和地方修订的定义可以更准确地绘制非传染性疾病地图,而对相关因素的分析支持改变行为以降低风险。法属波利尼西亚资助研究代表团(资助号03557/MED/REC-05/29/2019);ANR France2030-EPIGEMI(批准号ANR-23- chbs -0007);ANRS-MIE紧急情况(批准号23583)。
{"title":"Prevalence and associated factors of obesity, hypertension, and diabetes in French Polynesia: results from a nationwide cross-sectional study","authors":"Martin Paries ,&nbsp;Iotefa Teiti ,&nbsp;Maite Aubry ,&nbsp;Etienne Patin ,&nbsp;Yoann Madec ,&nbsp;Kiyojiken Chung ,&nbsp;Pauline Boucheron ,&nbsp;Stéphane Lastère ,&nbsp;Maëlia Etoundi ,&nbsp;Tuterarii Paoaafaite ,&nbsp;Lisa Dian ,&nbsp;Raphaëlle Bos ,&nbsp;André Wattiaux ,&nbsp;Caroline Michaux ,&nbsp;Henri-Pierre Mallet ,&nbsp;Lluis Quintana-Murci ,&nbsp;Arnaud Fontanet ,&nbsp;Van-Mai Cao-Lormeau","doi":"10.1016/j.lanwpc.2025.101746","DOIUrl":"10.1016/j.lanwpc.2025.101746","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;div&gt;Non-communicable diseases (NCDs) represent a major global health challenge, particularly in the Pacific. This study assessed the prevalence and associated factors of obesity, hypertension, and diabetes among adults in French Polynesia.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;A cross-sectional survey (2019–2021) was conducted on a nationally representative sample of adults across all five archipelagos (Tuamotu, Gambier, Marquesas, Austral, and Society including the Leeward and Windward Islands). Data included anthropometrics, blood pressure, biochemical markers (lipids, renal function), sociodemographic, lifestyle, and health history. NCDs were defined as hypertension (systolic BP &gt;140 mmHg, diastolic BP &gt;90 mmHg, and/or self-report of anti-hypertension medication use), diabetes (HbA1c &gt;6·5%, and/or self-report of previous medical diagnosis), and obesity (using either BMI ≥30 kg/m&lt;sup&gt;2&lt;/sup&gt; or a revised definition incorporating ethnicity-specific thresholds and additional anthropometric criteria).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Findings&lt;/h3&gt;&lt;div&gt;A total of 1893 adults were included (987 women; 906 men). Among them, 669 (weighted prevalence: 35·5%, 95% CI: 33–38) had hypertension, 214 (weighted prevalence: 12·2%, 95% CI: 10–14) had diabetes (including 53 undiagnosed, weighted prevalence: 3·1%, 95% CI: 2–4), and 1022 (weighted prevalence: 51·1%, 95% CI: 48–54) or 847 (weighted prevalence: 42·7%, 95% CI: 40–46) were classified as obese, using BMI-based or revised definitions, respectively. Among those with revised obesity, 439 (weighted prevalence: 52·2%, 95% CI: 48–57) presented metabolic abnormalities typically associated with the condition, while 408 (weighted prevalence: 47·8%, 95% CI: 43–52) were metabolically healthy, a phenotype that declined with age.&lt;/div&gt;&lt;div&gt;Women were less likely than men to have hypertension (OR = 0·59, 95% CI: 0·45–0·78), but more likely to present BMI-based obesity (OR = 1·61, 95% CI: 1·23–2·11). Hypertension odds were higher in Leeward versus Windward Islands (OR = 1·61, 95% CI: 1·24–2·09). Revised obesity was associated with low fruit/vegetable intake (OR = 1·53, 95% CI: 1·13–2·09), high meat consumption (OR = 1·52, 95% CI: 1·10–2·10), high fish consumption (OR = 1·54, 95% CI: 1·10–2·16), and low physical activity (OR = 1·58, 95% CI: 1·15–2·15). Obesity increased the odds of diabetes (OR = 2·99, 95% CI: 1·97–4·53) and hypertension (OR = 2·38, 95% CI: 1·80–3·14). Lower odds of obesity were observed in self-declared Polynesians of mixed ancestry (OR = 0·64, 95% CI: 0·42–0·96) and European immigrants (OR = 0·21, 95% CI: 0·07–0·61), as well as lower odds of diabetes in European immigrants (OR = 0·04, 95% CI: 0·01–0·19) compared to self-identified Polynesians.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Interpretation&lt;/h3&gt;&lt;div&gt;The high prevalence of obesity, a key driver of hypertension and diabetes, highlights the need for both population-wide prevention and targeted interventions across all archipelagos. Using standar","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"64 ","pages":"Article 101746"},"PeriodicalIF":8.1,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145569020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Lancet Regional Health: Western Pacific
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1